Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Tessera Stock

Q: How to sell Tessera stock?

If you hold private company shares of Tessera - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Tessera stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

www.tesseratherapeutics.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $558.91MM

Tessera Therapeutics is developing a genome engineering technology, Gene Writing™. The goal of Gene Writing™ is to be able to make genomic alterations that can be used to treat or cure disease. Tessera Therapeutics was founded in 2018 by Geoffrey von Maltzahn Ph.D., Jacob Rubens, Ph.D., and Noubar Afeyan, Ph.D. and is headquartered in Cambridge, MA.

Buy or sell Tessera stockLearn more about Tessera IPO

OverviewFinancingsValuation

Enterprise Value

Access Tessera’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Tessera.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Tessera investors also invested in these private companies

ARTIS Ventures

Cohesity, TAE Technologies, Rad AI, Versa Networks, Freenome, Eko Health, Tessera, Modern Meadow, Athena Club, Cerebral

Toba Capital

Wiz, M1 Finance, Papaya Global, Brex, WSO2, FloQast, Cockroach Labs, Tebra, Meati Foods, Mori

Flagship Pioneering

Indigo, Generate Biomedicines, Inari Agriculture, Tessera, Cellarity, Invaio, Alltrna, Inari

March Capital

Nile, Generate Biomedicines, Expel, Xage, SpyCloud, Essential AI, Acceldata, Tessera, Overjet

TA Ventures

The Farmer's Dog, DeepL, Nuro, Turo, Universal Hydrogen, Pipe, Stoke Space, Apex, MasterClass, VidAngel

Longevity Vision Fund

Insilico Medicine, Freenome, Eko Health, Tessera, Cambrian

Team

Management Team

Hari Pujar Ph.D

Chief Operating Officer

Madhusudan Peshwa Ph.D

Chief Technology Officer, Cell Therapy

Michael Holmes Ph.D

Chief Scientific Officer

Iain McFadyen Ph.D

Chief Data Officer

Anne-Virginie Eggimann

Chief Regulatory Officer

Michael Severino MD

Chief Executive Officer & Board Member

Howard Liang Ph.D

Chief Financial Officer & President

David Davidson MD

Chief Medical and Development Officer

Tessera stock FAQs

Can you buy Tessera stock?

As Tessera is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Tessera, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Tessera stock?

To invest in a private company like Tessera through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Tessera stock?

Yes, you may be able to sell your Tessera stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Tessera stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Tessera stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Tessera a public company?

No, Tessera is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Tessera’s stock price?

Tessera is a privately held company and therefore does not have a public stock price. However, you may access Tessera’s private market stock price with Forge Data.

What is Tessera’s stock ticker symbol?

Tessera does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

The Scientist 12/12/2022

Can “Gene Writing” Deliver What Gene Editing Can’t?

For the past few years, a biotech company called Tessera Therapeutics has been working away with a singular, lofty goal in mind: revolutionizing the technology used to edit DNA and RNA for scientific or therapeutic purposes.

Bloomberg's Baystate Business Podcast 04/25/2022

Tessera CEO Interview

Tessera therapeutics has invented a tool for gene writing... Giving promise to entirely new disease therapies and prevention - at the genetic level.

Bloomberg 04/19/2022

Flagship-Backed Tessera Raises $300 Million for Gene-Fixing Tech

Tessera Therapeutics, a company developing a genetic approach to treat and prevent diseases with backing from Flagship Pioneering, raised more than $300 million in its latest round.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.